State Regulator Bans Wockhardt Drug
India drugmaker Wockhardt Ltd said on Wednesday that the Himachal Pradesh state drug controller has suspended the manufacture, sale or distribution of the company's fixed-dose combo painkiller.
GSK Bribery Probe Expands to Five Countries
GSK is now investigating claims that staff in Jordan and Lebanon may have bribed doctors, adding to last year's bribery allegations in China, as well as the more recent allegations in Iraq and Poland.
J&J Gives Up On Botox Rival
J&J announced last week that it will abandon efforts to bring to market a rival drug to Allergan's popular anti-wrinkle treatment, Botox.
India's Lupin Recalls Antibiotic in U.S.
Mumbai-based drugmaker Lupin is recalling ten thousand bottles of its Suprax antibacterial drugs after finding that they failed to meet U.S. standards for impurities.
More Antitrust Probes for Novartis, Roche
France's competition authority is investigating Swiss drugmakers Roche and Novartis on suspicion they were involved in anti-competitive practices in relation to the distribution of their eye disease treatments.
Takeda, Lilly Fined $9B for Hiding Cancer Risks
A Louisiana federal court ordered Takeda Pharmaceutical Co. and Eli Lilly & Co. to pay a combined $9 billion in punitive damages after a jury found they covered up the cancer risks of their Actos diabetes drug.